a decreasing trendp = 0.034
Patients in the M0–M2– group showed a decreasing trend in OS and PFS compared to patients in the M0 + M2 + group (mOS: 7 vs. 15 months, p = 0.034; mPFS: 3 vs. 7 months, p = 0.038) (Fig. 3 C, D).
Patients in the M0–M2– group showed a decreasing trend in OS and PFS compared to patients in the M0 + M2 + group (mOS: 7 vs. 15 months, p = 0.034; mPFS: 3 vs. 7 months, p = 0.038) (Fig. 3 C, D).